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Background-—We hypothesized that female sex is a treatment effect modifier of blood flow and related 30-day mortality after
primary percutaneous coronary intervention (PCI) for ST-segment–elevation myocardial infarction and that the magnitude of the
effect on outcomes differs depending on delay to hospital presentation.
Methods and Results-—We identified 2596 patients enrolled in the ISACS-TC (International Survey of Acute Coronary Syndromes
in Transitional Countries) registry from 2010 to 2016. Primary outcome was the occurrence of 30-day mortality. Key secondary
outcome was the rate of suboptimal post-PCI Thrombolysis in Myocardial Infarction (TIMI; flow grade 0–2). Multivariate logistic
regression and inverse probability of treatment weighted models were adjusted for baseline clinical covariates. We characterized
patient outcomes associated with a delay from symptom onset to hospital presentation of ≤120 minutes. In multivariable
regression models, female sex was associated with postprocedural TIMI flow grade 0 to 2 (odds ratio [OR], 1.68; 95% CI, 1.15–
2.44) and higher mortality (OR, 1.72; 95% CI, 1.02–2.90). Using inverse probability of treatment weighting, 30-day mortality was
higher in women compared with men (4.8% versus 2.5%; OR, 2.00; 95% CI, 1.27–3.15). Likewise, we found a significant sex
difference in post-PCI TIMI flow grade 0 to 2 (8.8% versus 5.0%; OR, 1.83; 95% CI, 1.31–2.56). The sex gap in mortality was no
longer significant for patients having hospital presentation of ≤120 minutes (OR, 1.28; 95% CI, 0.35–4.69). Sex difference in post-
PCI TIMI flow grade was consistent regardless of time to hospital presentation.
Conclusions-—Delay to hospital presentation and suboptimal post-PCI TIMI flow grade are variables independently associated with
excess mortality in women, suggesting complementary mechanisms of reduced survival.
Clinical Trial Registration-—URL: http://www.clinicaltrials.gov. Unique identifier: NCT01218776. ( J Am Heart Assoc. 2019;8:
e011190. DOI: 10.1161/JAHA.118.011190.)
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P ossible sex-based differences with respect to atheroscle-rotic disease have become a subject of intense research
and debate. Atherosclerosis tends to affect men and women
differently and at different times in their lives. One of the most
intriguing findings is that women presenting with ST-segment–
elevationmyocardial infarction (STEMI) diemoreoften thanmen
irrespective of reperfusion modalities.1–7 These findings have
raised the physician’s interest in finding out more about the
reasons for this large sex gap. Yet, such information is missing
because studies on pathophysiological characteristics of
ischemic heart disease have mainly focused on women with
the exclusion or underrepresentation of men.8
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Coronary blood flow is a major determinant of patients’
prognosis.9 Restoration of blood flow after recanalization of
the infarct-related artery is commonly quantified with the
Thrombolysis in Myocardial Infarction (TIMI) grading system.10
Failure to account for sex differences in coronary blood flow
after primary percutaneous coronary intervention (PCI) could
explain contradictory findings on the rates of mortality among
women and men.11 Abnormal coronary reactivity and
microvascular dysfunction are more prevalent among
women12 and may be associated with lower TIMI flow grades
and adverse outcomes. In addition, myocardial regions
subjected to prolonged ischemia exhibit loss of microvascular
integrity with endothelial swelling and edema.13 The extent of
lesion depends on the duration of ischemia, and women have
longer delays to hospital presentation compared with
men.4,5,14
The purpose of our study was to characterize clinical and
angiographic variables potentially associated with suboptimal
coronary blood flow and their association with outcomes in a
large cohort of patients undergoing primary PCI. The primary
hypothesis was that post-PCI coronary blood flow might differ
for men and women and may partially account for increased
30-day mortality among women. We also hypothesized that
the magnitude of the effect on outcomes differs depending on
delay to hospital presentation.
Methods
Study Population
The authors declare that all supporting data are available
within the article and its supplemental material.
The ISACS-TC (International Survey of Acute Coronary
Syndromes in Transitional Countries; ClinicalTrials.gov:
NCT01218776) registry is a large, prospective, multicenter
cohort study designed to record clinical characteristics,
treatments, and clinical outcomes for patients with acute
coronary syndrome.5,15 The ISACS-TC registry enrolled 5590
patients who underwent primary PCI for STEMI within 12 hours
from symptom onset between January 2010 and January 2016.
The designated physician collected the registry data at the time
of clinical assessment. Patients were asked about the quality of
their symptoms. All patients presented with chest pain or
equivalent symptoms, such as dyspnea and fatigue. Data on
coronary hemodynamics were available in 2651 of the 5590
patients. In the remaining patients, the ISACS-TC registry
generated reports with summarizing information on PCI
procedural success without any further detail. Among the
2651 patients with data on coronary hemodynamics, those
who had an unknown time of symptom onset (n=55) were
excluded, giving a final study population of 2596 patients
(Figure). Patients who were transferred from a PCI noncapable
hospital were included in this analysis. Time of symptom onset
relied on patient recall and required documentation by each
hospital participating in this registry. Delay time from symptom
onset to hospital presentation included door-in to door-out
time, defined as the duration of time from arrival to discharge at
the first referral hospital, and transfer time to a STEMI receiving
hospital for primary PCI. Because delay times are a continuous
variable, we characterized time to reperfusion and patient
outcomes associated with a time from symptom onset to
hospital presentation of ≤120 minutes and door-to-balloon
time of ≤90 minutes according to prior work.4,14 The local
research ethics committee from each hospital approved the
study. The data-coordinating center has been established at
the University of Bologna (Bologna, Italy). The study was
approved by the local research ethics committee from each
hospital. Because patient information was collected anony-
mously, institutional review boards waived the need for
individual informed consent.
Outcomes
The primary outcome was the incidence of 30-day all-cause
mortality. Key secondary outcome was the incidence of
suboptimal TIMI flow grade 0 to 2 after PCI. We also studied
the likelihood of having ischemic stroke and bleeding compli-
cations. Ischemic stroke was diagnosed on the basis of an
imaging study. Bleeding complications were defined as
Clinical Perspective
What Is New?
• In the current study, compared with men, postprocedural
Thrombolysis in Myocardial Infarction flow grade rates were
lower and 30-day mortality was higher in women.
• The distribution of covariates was similar between women
and men.
• Delay to hospital presentation also modified comparative
effectiveness between sexes because the sex gap in
mortality was no longer significant for patients presenting
to hospital within 120 minutes.
What Are the Clinical Implications?
• Differences between men and women in post primary
percutaneous coronary intervention mortality rates exist
even when women and men are balanced in terms of
baseline characteristics, treatment, and time to hospital
presentation.
• Delay to hospital presentation and suboptimal postproce-
dural Thrombolysis in Myocardial Infarction flow grade are
variables independently associated with excess mortality in
women, suggesting complementary mechanisms of reduced
survival.
• Sex as a biological variable should be factored into research
designs, analyses, and reporting in human studies.
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previously reported by the TIMI definitions.16 Decreases in
hemoglobin ≥5 g/dL occurring during hospitalization or
intracranial hemorrhage classified bleeding as major. The use
of medications given at hospital admission was also noted.
TIMI Flow Grading
The TIMI flow of the infarct artery was estimated before and
after completion of PCI, according to 4 grades of flow, as
previously described.10 In brief, grade 0 perfusion is no
antegrade flow beyond the point of occlusion; grade 1 is faint
antegrade coronary flow beyond the occlusion with incom-
plete filling of the distal coronary bed; grade 2 is complete but
delayed filling of distal coronary bed; and grade 3 is normal
flow with complete filling of the distal bed at a normal rate.
Patients were divided into 2 groups on the basis of the
postprocedural TIMI flow in the ischemia-related artery: TIMI
grades ≤2 (no reflow) and TIMI grade 3. The definition of no
reflow required the absence of coronary dissection or
significant (≥25%) residual stenosis that could have caused
a decrease in coronary blood flow.17
Statistical Analysis
Patient and procedure characteristics were examined accord-
ing to sex. Statistical testing was performed with the use of
the Pearson’s v² test for categorical variables and the 2-
sample t test for continuous variables. We had complete
data on time from symptom onset to PCI and mortality.
Some patients had missing data on other variables. We
imputed the missing values of the clinical variables whose
missing rate was <10% using IVEWARE software.18 Only 1
variable, Killip class, had missing rates that exceeded 10%.
We used k-nearest neighbor algorithms as imputation
method19–21 (Data S1). Estimates of the odds ratios (ORs)
and associated 95% CIs were obtained with the use of
multivariable logistic regressions. Fixed covariates included
demographic information and baseline clinical characteristics
(Tables 1 and 2). We stabilized weights to reduce the
variability and ensure that the estimated treatment effect
remains balanced.22 Weighted t tests and weighted v2 tests
were used in the inverse probability of treatment weighting
(IPTW) analyses to compare continuous or categorical
variables in women and men (Data S1). Furthermore, to
assess significant heterogeneity of outcomes in function of
sex and delay from symptom onset to hospital presentation,
we made statistical comparisons across 2 delay cohorts
(<120 and ≥120 minutes). We used IPTW because it is the
simplest method that adjusts for the confounding effect of
time-varying covariates.23 Multivariable-adjusted regression
was inadequate in controlling time-varying confounding24
and was not used for this task (Data S1).
Figure. Flow diagram. STEMI indicates ST-segment–elevation myocardial infarction.
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Results
Similarities and differences between women and men excluded
from the present analysis are shown in Table S1. Among the
2596 patients enrolled in the study, there were 1923 men (74%)
and 673 women (26%) (Table 1). There was an imbalance of
clinical covariates between women and men, as shown by the
optimized regression coefficient (b) and constant term (a) for
the logistic regression (Table S2). Women presented at an older
age than men. They were more likely to have diabetes mellitus,
hypertension, and congestive heart failure, but less likely to
have a history of smoking. Crude mortality rates among women
and men were 5.9% versus 2.3%. Angiograms revealed 8.1% of
women and 4% of men with post-PCI TIMI flow grade 0 to 2.
Table 1. Baseline Characteristics of Patients With STEMI Sorted by Sex
Characteristics Women (N=673) Men (N=1923) P Value
Age, meanSD, y 64.811.5 58.811.1 <0.001
Cardiovascular risk factors, n (%)
Family history of CAD 224 (33.3) 595 (30.9) 0.265
Diabetes mellitus 163 (24.2) 392 (20.4) 0.043
Hypertension 500 (74.3) 1198 (62.3) <0.001
Hypercholesterolemia 340 (50.5) 838 (43.6) 0.002
Current smoking 278 (41.3) 1023 (53.2) <0.001
Former smoking 45 (6.7) 286 (14.9) <0.001
Previous cardiovascular disease, n (%)
Previous angina pectoris 160 (23.8) 354 (18.4) 0.004
Previous myocardial infarction 36 (5.3) 149 (7.7) 0.024
Previous PCI 12 (1.8) 88 (4.6) <0.001
Previous CABG 0 (0.0) 11 (0.6) 0.001
Peripheral artery disease 5 (0.7) 27 (1.4) 0.121
Previous heart failure 38 (5.6) 95 (4.9) 0.488
Previous stroke 16 (2.4) 46 (2.4) 0.983
Clinical presentation
ST-segment elevation in anterior leads, n (%) 232 (34.5) 745 (38.7) 0.047
Killip class ≥2, n (%) 100 (14.9) 215 (11.2) 0.018
Systolic blood pressure at baseline, meanSD, mm Hg 134.626.6 136.624.5 0.094
Heart rate at baseline, meanSD, beats/min 79.317.6 79.417.0 0.854
Serum creatinine at baseline, meanSD, lmol/L 79.044.7 94.452.3 <0.001
Medications administered within 24 h from admission, n (%)
Aspirin 667 (99.1) 1914 (99.5) 0.283
Clopidogrel 663 (98.5) 1856 (96.5) 0.001
Unfractionated heparin 377 (56.0) 1118 (58.1) 0.340
Low-molecular-weight heparins 318 (47.3) 933 (48.5) 0.571
Heparins (overall) 627 (93.2) 1809 (94.1) 0.415
Glycoprotein IIb/IIIa inhibitor 121 (18.0) 363 (18.9) 0.604
Outcomes
30-d Mortality, n (%) 40 (5.9) 45 (2.3) <0.001
30-d Mortality, OR (95% CI) 2.64 (1.66–4.17) <0.001
TIMI flow grade ≤2, n (%) 54 (8.0) 91 (4.7) 0.004
TIMI flow grade ≤2, OR (95% CI) 1.76 (1.21–2.52) 0.002
CABG indicates coronary artery bypass graft; CAD, coronary artery disease; OR, odds radio; PCI, percutaneous coronary intervention; STEMI, ST-segment–elevation myocardial infarction;
TIMI, Thrombolysis in Myocardial Infarction.
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Angiographic and Procedural Characteristics
Procedural characteristics stratified by sex are illustrated in
Table S3. Women and men had similar rates of preprocedural
TIMI flow grade 3 (26.4% versus 31.1%; P=0.13). There was no
sex difference in frequency of multivessel disease, acute
vessel closure, acute thrombosis, and bifurcation lesions.
Bleeding complications and ischemic strokes occurred infre-
quently and were not significantly different between the 2
groups.
Balancing Covariates: Descriptive Baseline
Comparison
Standard parametric adjustment by regression could be
sensitive to model misspecification when groups differ
greatly, as we observed in our population for women versus
men. We, therefore, balanced the distribution of covariates
using a nonparametric balancing strategy by weighting
(IPTW). The 2 groups (women and men) were well balanced
(Table 2). The primary outcome of death occurred in 4.8%
of women compared with 2.5% of men (reference, men; OR,
2.00; 95% CI, 1.27–3.15). Moreover, we found a significant
sex difference in the secondary outcome of post-PCI TIMI
flow grade ≤2 (reference, men; OR, 1.83; 95% CI, 1.31–
2.56). To determine the relation between sex and severe no
reflow complicating primary PCI, we excluded patients who
had TIMI flow grade 2. The sex difference in the incidence
of TIMI flow grade ≤1 was similar (OR, 1.51; 95% CI, 1.02–
2.26) to that seen for the entire cohort (TIMI flow grade ≤2)
(Table S4).
Table 2. IPTW: Women Versus Men
Characteristics Women (n=673) Men (n=1923) P Value
Age, meanSD, y 61.811.6 60.311.4 0.003
Cardiovascular risk factors, %
Family history of CAD 34.9 31.9 0.153
Diabetes mellitus 22.5 21.2 0.480
Hypertension 68.4 65.0 0.109
Hypercholesterolemia 46.6 44.0 0.243
Current smoking 47.9 50.2 0.304
Former smoking 9.5 12.6 0.031
Previous cardiovascular disease, %
Previous angina pectoris 20.7 19.4 0.466
Previous myocardial infarction 5.6 7.1 0.180
Previous PCI 1.9 3.9 0.013
Previous CABG 0 0.4 0.112
Peripheral artery disease 0.7 1.2 0.286
Previous heart failure 5.2 5.1 0.919
Previous stroke 3.0 2.4 0.398
Clinical presentation at admission
ST-segment elevation in anterior leads, % 37.4 37.7 0.890
Killip class ≥2, % 19.2 19.3 0.954
Systolic blood pressure at baseline, meanSD, mm Hg 134.827.6 136.024.3 0.324
Heart rate at baseline, meanSD, beats/min 79.017.2 79.217.4 0.809
Serum creatinine at baseline, meanSD, lmol/L 77.828.2 91.746.4 <0.0001
Outcomes
30-d Mortality, % 4.8 2.5 0.0024
30-d Mortality, OR (95% CI) 2.00 (1.27–3.15) 0.0029
TIMI flow grade ≤2, % 8.8 5.0 0.0003
TIMI flow grade ≤2, OR (95% CI) 1.83 (1.31–2.56) 0.0004
CABG indicates coronary artery bypass graft; CAD, coronary artery disease; IPTW, inverse probability of treatment weighting; OR, odds radio; PCI, percutaneous coronary intervention; TIMI,
Thrombolysis in Myocardial Infarction.
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Multivariable Analysis of Baseline Clinical Factors
Associated With Outcomes
To reinforce our data, we also estimated the multivariable-
adjusted effect of PCI on TIMI flow grade 0 to 2 and 30-day
mortality. Although the odds of a multivariable-adjusted
regression cannot calculate the absolute risk, female sex
was still a predictor variable for the association with post-
procedural TIMI flow grade 0 to 2 (OR, 1.68; 95% CI, 1.15–
2.44) (Table S5) and 30-day mortality (OR, 1.72; 95% CI,
1.02– 2.90) (Table S6). It follows that linear regression
adjustment resulted in conclusions similar to those obtained
using IPTW methods.
Delay to Hospital Presentation
Median time from symptom onset to hospital presentation
was longer for women (280 versus 240 minutes), with only
23.2% of women versus 29.1% of men having a <120-minute
delay from symptom onset to admission (P=0.002) (Table S7).
There were no differences between sexes in median door-to-
balloon time (40 versus 38 minutes). The unadjusted risk of
mortality increased with increasing time from symptom onset
to hospital presentation (Figure S1). We therefore explored
whether female sex could be a contributing factor that
increases the risk of mortality when hospital presentation
times were comparable among women and men.
Sex Differences in Outcomes in Function of Delay
to Hospital Presentation
We assessed how differences in time to hospital presentation
could translate into sex-specific PCI outcomes using IPTW
(Table 3). For delayed time to hospital presentation ≥120-
minute benchmark, the mortality rates were 5.5% in women
and 2.8% in men. When women and men presented to hospital
within 120 minutes, their outcomes were equally positive
(2.0% versus 1.6%). On the contrary, the incidence of post-PCI
TIMI flow grade ≤2 rate was higher in women compared with
men regardless of time to hospital presentation: 9.4% versus
6.3% in patients with delay to hospital presentation >120
minutes and 7.9% versus 1.6% in those with delay <120
minutes.
Delay to Treatment and Mortality in “Flow
Benefiters”
We wanted to create a challenge in defining the effect of delay
to hospital presentation on the primary outcome of 30-day
mortality independently of the occurrence of suboptimal
blood flow (grade 0–2). We, therefore, restricted our analysis
to patients who fully benefited from PCI intervention (TIMI
flow grade 3) (Table 4). The results were consistent with,
although smaller in effect size than, those seen in the overall
population. There were sex differences for late STEMI
presentations (delay to hospital presentation ≥120 minutes),
with women having worse outcomes (3.9% versus 2.0%; OR,
1.94; 95% CI, 1.06–3.57). In contrast, there was no significant
difference in the rates of death in women and men with timely
(<120-minute) hospital presentation (1.1% versus 1.4%; OR,
0.74; 95% CI, 0.13–4.26).
Delay to Treatment and Mortality in Patients With
TIMI Flow Grade 0 to 2
Next, we focused on patients who did not benefit from PCI
intervention (TIMI flow grade 0–2). Figure S2 summarizes the
relationship between delay to hospital presentation and
mortality in patients with post-PCI TIMI flow grades 0 to 2.
The incidence of post-PCI TIMI flow grades 0 to 2 in the
overall population was 8.0% in women and 4.7% in men
(Table 1). The unadjusted 30-day mortality rates associated
with post-PCI TIMI flow grades 0 to 2 were 2.5% in women
and 0.5% in men. Sex differences in patients with early,
within 120 minutes, hospital presentations were comparable
to those of the overall population (Table 3). There was a
large difference in the incidence of post-PCI TIMI flow grades
0 to 2 between women and men (7.9% versus 1.7%). Sex
differences were less pronounced in late hospital presenta-
tions, in which the incidence of post-PCI TIMI flow grades 0
to 2 was 9.4% in women and 6.3% in men. Unadjusted
mortality rates in patients with TIMI flow grades 0 to 2 were
>2-fold higher in women compared with men in either early
or late hospital presentation (28.6% versus 10.0% and 31.9%
versus 11.1%, respectively). TIMI flow grades 0 to 2
remained a correlate of higher 30-day mortality in women
versus men even after removing confounding by IPTW
(Tables S8 and S9).
Age Groups and TIMI Flow Grade 0 to 2
We investigated the role of sex and age on TIMI flow by
stratifying patients into 2 groups: aged <60 and ≥60 years.
TIMI flow grades 0 to 2 remained an independent correlate of
female sex only in patients aged ≥60 years (OR, 1.56; 95% CI,
1.08–2.26) (Tables S10 and S11).
Discussion
Sex differences in mortality can be seen only in patients with
STEMI.25–33 Many of the differences in outcomes have been
attributed to sex differences in treatment because women
present to hospital later than men and are less likely to
undergo primary PCI.30,31 There are few studies addressing
the issue of sex differences in outcome after primary
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PCI.1–7,32,34–37 Yet, most of these studies still documented
persistently higher rates of adverse events in women
compared with men.1–7 The unsolved issue remains why?
The Current Study
The main findings of the current study are: (1) women have
lower procedural success as assessed by post-PCI TIMI 3 flow
regardless of time to hospital presentation; (2) time to
hospital presentation correlates with 30-day mortality; (3) for
late STEMI presentations, women have higher mortality rates
than men; (4) when women and men present for STEMI within
120 minutes of symptom onset, their outcomes are equally
positive. These findings suggest the existence of an important
sex-by-PCI treatment interaction. Furthermore, these findings
demonstrate that delay to hospital presentation modifies the
effects of PCI between sexes. Delay and suboptimal postpro-
cedural TIMI flow grade are variables independently associ-
ated with excess mortality in women, suggesting
complementary mechanisms of reduced survival. These
outcomes raise several significant methodological and clinical
issues.
Women Have Lower Procedural Success
We know that failure to achieve post-PCI TIMI 3 flow
correlates with mortality.38,39 The different twist of this study
is that it demonstrates that failure to achieve post-PCI TIMI 3
Table 3. IPTW: Women Versus Men Sorted by Delay Cohorts
Variable
Timely (<120-min) PCI Delayed (≥120-min) PCI
Women (n=156) Men (n=560) P Value Women (n=517) Men (n=1363) P Value
Age, meanSD, y 61.211.6 58.211.1 0.003 62.111.5 61.111.4 0.093
Cardiovascular risk factors, %
Family history of CAD 34.3 34.5 0.963 33.9 31.0 0.228
Diabetes mellitus 17.7 16.3 0.678 23.8 23.1 0.748
Hypertension 68.7 59.9 0.045 69.3 66.9 0.321
Hypercholesterolemia 45.2 43.6 0.722 48.0 44.3 0.150
Current smoking 58.2 56.7 0.738 44.4 47.6 0.214
Former smoking 4.0 10.6 0.011 11.2 13.4 0.202
Previous cardiovascular disease, %
Previous angina pectoris 20.0 17.6 0.491 20.9 20.1 0.701
Previous myocardial infarction 7.0 9.4 0.351 6.0 6.4 0.749
Previous PCI 3.1 6.1 0.145 1.6 3.0 0.089
Previous CABG 0 0.3 0.4813 0 0.5 0.101
Peripheral artery disease 0.8 0.9 0.9041 0.7 1.4 0.217
Previous heart failure 6.8 4.0 0.140 5.4 5.6 0.866
Previous stroke 4.1 1.9 0.112 2.8 2.7 0.905
Clinical presentation at admission
ST-segment elevation in anterior leads, % 42.4 42.7 0.946 34.9 35.9 0.686
Killip class ≥2, % 15.6 13.7 0.547 20.2 21.5 0.538
Systolic blood pressure at baseline, meanSD, mm Hg 137.226.4 135.723.7 0.503 134.927.6 136.224.5 0.354
Heart rate at baseline, meanSD, beats/min 77.113.5 77.8169 0.669 79.117.6 79.717.5 0.475
Serum creatinine at baseline, meanSD, lmol/L 72.819.4 90.735.4 <0.0001 78.228.8 92.150.2 <0.001
Outcomes
30-d Mortality, % 2.0 1.6 0.713 5.5 2.8 0.004
30-d Mortality, OR (95% CI) 1.28 (0.35–4.69) 0.714 2.03 (1.23–3.33) 0.005
TIMI flow grade ≤2, % 7.9 1.7 0.0001 9.4 6.3 0.02
TIMI flow grade ≤2, OR (95% CI) 4.82 (2.04–11.41) 0.0003 1.54 (1.07–2.23) 0.021
CABG indicates coronary artery bypass graft; CAD, coronary artery disease; IPTW, inverse probability of treatment weighting; OR, odds radio; PCI, percutaneous coronary intervention; TIMI,
Thrombolysis in Myocardial Infarction.
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is one of the keys to explain mortality difference between
sexes. The reasons for these procedure-associated differences
in TIMI flow rates cannot be explained by the data of this
registry and should be further investigated. We can just assume
that suboptimal reperfusion after primary PCI is related to
microvascular disorders resulting from coronary vasospasm
secondary to endothelial injury and/or distal embolization,40
and women have a higher frequency of coronary plaque erosion
and microembolization that could result in more microvascular
dysfunction than men.41 The central point we must underline,
however, is that women with STEMI have a worse outcome, and
this is likely attributable to a combination of factors. Indeed,
only 2.5% of women and 0.5% of men died with a post-PCI TIMI
flow grade ≤2, whereas the overall mortality rates were much
greater (ie, 5.9% and 2.3%, respectively). Thus, other mecha-
nisms for excess mortality in women are operating, which
cannot be explained by established cardiovascular risk factors
or whether patients received conventional treatment by
primary PCI.
Time to Hospital Presentation Correlates With
30-Day Mortality
Time to reperfusion is clearly linked with myocardial salvage,
and it makes sense that more rapid reperfusion should impact
outcome. Myocardial cell death starts soon after arterial
occlusion, and the myocardial salvage one can expect from
reperfusion decreases sharply between 2 and 3 hours.42 After
120 minutes, the benefit with respect to myocardial salvage
is of limited magnitude. Previous studies have documented a
strict relationship between total ischemic time and 1-year
mortality in patients treated with primary PCI43: every 30-
Table 4. IPTW: PCI Treatment Effect on 30-Day Mortality in “Flow Benefiters”
Characteristics
Timely (<120-min) PCI Delayed (≥120-min) PCI
Women (N=143) Men (N=549) P Value Women (N=469) Men (N=1278) P Value
Age, meanSD, y 61.711.1 57.911.0 0.0003 62.311.7 60.911.4 0.023
Cardiovascular risk factors, %
Family history of CAD 33.6 35.0 0.754 34.4 31.7 0.285
Diabetes mellitus 20.1 16.1 0.256 24.8 23.2 0.485
Hypertension 69.2 59.5 0.033 69.7 66.6 0.220
Hypercholesterolemia 45.0 43.6 0.764 48.3 44.2 0.127
Current smoking 59.0 57.1 0.683 43.9 47.8 0.148
Former smoking 4.7 10.5 0.033 10.9 13.3 0.181
Previous cardiovascular disease, %
Previous angina pectoris 21.0 17.3 0.306 21.1 19.8 0.548
Previous myocardial infarction 7.5 9.9 0.382 5.2 6.3 0.392
Previous PCI 0.3 6.3 0.126 1.5 3.2 0.052
Previous CABG 0 0.3 0.507 0 0.5 0.132
Peripheral artery disease 0.8 0.9 0.909 1.0 1.1 0.855
Previous heart failure 7.5 4.1 0.089 5.2 5.7 0.686
Previous stroke 3.6 1.7 0.157 3.3 2.7 0.505
Clinical presentation at admission
ST-segment elevation in anterior leads, % 39.0 41.5 0.588 33.8 34.6 0.755
Killip class ≥2, % 15.1 13.0 0.512 19.4 19.8 0.852
Systolic blood pressure at baseline, meanSD, mm Hg 137.228.2 135.823.5 0.555 134.828.0 136.624.4 0.210
Heart rate at baseline, meanSD, beats/min 76.613.2 77.416.5 0.616 79.518.2 79.617.3 0.911
Serum creatinine at baseline, meanSD, lmol/L 73.319.2 89.833.8 <0.001 79.028.8 90.245.9 <0.001
Outcomes
30-d Mortality, % 1.1 1.4 0.732 3.9 2.0 0.029
30-d Mortality, OR (95% CI) 0.74 (0.13–4.26) 0.732 1.94 (1.06–3.57) 0.032
CABG indicates coronary artery bypass graft; CAD, coronary artery disease; IPTW, inverse probability of treatment weighting; OR, odds radio; PCI, percutaneous coronary intervention.
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minute delay before reperfusion, the relative risk of mortality
increases by 7.5%. North American and European guidelines
recommend primary PCI as the preferred reperfusion strategy
over thrombolysis in patients with STEMI, provided it can be
performed within 120 minutes from diagnosis.44,45 The
American Heart Association established “Mission: Lifeline”
to develop STEMI systems of care that would improve timely
access to PCI.46 However, despite the increased focus on
delays in STEMI care, it is difficult to translate guideline
recommendations into clinical practice. The NCDR (National
Cardiovascular Data Registry) found that only 15% of patients
are treated within 120 minutes from symptom onset.47 In the
current study, we examined the prehospital and hospital
components of the total ischemic time: time from symptom
onset to hospital presentation and door-to-balloon time. We
found that the median time from symptom onset to hospital
presentation ranged from 280 minutes in women to 240 min-
utes in men and that the median door-to-balloon times of
women and men were 40 and 38 minutes, respectively. Much
more important, we found that the proportions of men and
women with time from symptom onset to hospital presenta-
tion within 120 minutes were only 23.2% and 29.1%, respec-
tively. Women and men with the longer delay time had the
higher risk of 30-day mortality compared with those with
shorter delay times. Given these data, we focused more on
time from symptom onset to hospital presentation rather than
focusing on door-to-balloon time. Indeed, the median door-to-
balloon times of our patients were generally within the
guideline-endorsed time frame of ≤90 minutes. Door-to-
balloon time only measures the delay to reperfusion once
patients reach the hospitals, which constitutes a smaller
fraction of the total ischemic time. Women were more likely to
exceed reperfusion times than men in the prehospital phase
of the total ischemic time.
Early Versus Late STEMI Presentation and Sex
Difference in Outcomes
The main concern was that sex is correlated with delays, and
sex effect may have been masked by the delay effect. Patients
were, therefore, stratified in 2 delay cohorts: those with time
of symptom onset to hospital presentation up to 120 minutes
or later and those with time within 120 minutes. The cutoff of
120 minutes was based on previous work.4,14,27,33,48,49 The
main finding of such analysis can be summarized as follows.
For late STEMI presentations, women have higher mortality
rates than men (OR, 2.03; 95% CI, 1.23–3.33). As the delay to
hospital presentation decreased to <120 minutes, the car-
diovascular risk of women became similar to that of men (OR,
1.28; 95% CI, 0.35–4.69). Interestingly, women have lower
procedural success, as assessed by post-PCI TIMI 3 flow,
regardless of time to hospital presentation, which suggests
that delay to hospital presentation and suboptimal postpro-
cedural coronary blood flow are independent mechanisms
responsible for sex differences in outcomes. As so, female sex
may be a biological variable.50
Female Sex as a Biological Variable
Little attention has been paid to provide experimental designs
for comparative assessment of sex-specific modifications in
myocardial tissue and blood flow during myocardial infarction.
Few explanations, therefore, may account for our findings. One
possibility is that the initial process of infarct healing after
STEMI is different among women and men. Female animals
show a greater number of macrophages in their ischemic
areas.51 Macrophages facilitate inward remodeling in arterial
vessels, causing further reduction in blood flow with poorer
myocardial perfusion. Another possibility is that impaired
myocardial perfusion after PCI may be facilitated in women
because they have smaller coronary artery size. A report from
the Zwolle investigators52 demonstrated a significant associ-
ation between small vessel size (<3 mm) and poor perfusion.
As a final point, susceptibility to ischemia injury may also be
sex dependent.53 Perhaps reduced collateral flow in women
may account for more vulnerability to prolonged untreated
ischemia after coronary obstruction and more reperfusion
injury. This may lead to more complications, including a higher
incidence of shock, ventricular septal rupture, and severe
mitral regurgitation.
Testing Hypotheses by IPTW Models
Estimating the effect of treatments on sex-related responses is
one of the crucial problems in resolving gender/sex issues.
Indeed, treatment disparities may account for a portion of
adverse outcomes, leaving uncertainty about the size of the
problem and comparability of different series reported.28
Matched-pairs designs are commonly implemented in the field
of medical research to eliminate confounding and improve
study efficiency. We matched patients using IPTW models.
IPTW is based on the propensity score and has specific
advantages in comparison with regression adjustment. Advan-
tages include the ability to present a balance of covariates,
which removes most of the confounding, a property that would
be expected under randomization,22 and the ability to control
for many covariates. Matching by IPTW reduces statistical
power to a lower extent than adjustments in the model.54,55
Multiple Mediators of Excess Mortality in Women
We examined whether the combination of suboptimal post-
PCI blood flow and longer delays from symptom onset to
hospital presentation may increase the risk of death in women
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compared with men, over and beyond the separate effect of
each single factor. We defined 4 clinical scenarios. Patients
admitted to hospital within 120 minutes having post-PCI
complete restoration of blood flow (scenario 1) were the most
robust patients because they had the lowest mortality
(Table 4). Patients admitted to hospital later and having
suboptimal postprocedural flow (scenario 2) were the frailest
subjects (Table S9). However, their outcomes did not differ so
much from those of patients presenting within 120 minutes
from their symptom onset, but still with post-PCI TIMI flow
grades 0 to 2 (scenario 3) (Table S8). Scenario 4 (Table 4)
included patients presenting to hospital later than 120 minutes
but with post-PCI complete restoration of blood flow. In these
patients, mortality rates were twice as high as those reported in
scenario 1, but consistently less than those seen in patients
with TIMI flow grades 0 to 2 (scenarios 2 and 3). These findings
indicate that female sex is associated with multiple indepen-
dent pathways leading to excess mortality after primary PCI for
STEMI. It is remarkable that post-PCI TIMI flow grade 0 to 2 is
associated with a much higher risk of mortality compared with
the risk for patients with normal post-PCI TIMI flow grade. This
relationship persists regardless of time to hospital presenta-
tion, and its magnitude is much greater for women than men.
Suboptimal post-PCI blood flow accounts for a part of the
observed sex differences in outcomes. Further studies are
required to clarify the mechanisms underlying the persisting
female disadvantage in patients with longer delays to hospital
presentation. This information is of foremost importance to
reduce the sex gap in mortality.
Myocardial Infarction in Younger Versus Older
Women
Sex differences in mortality rates have been shown to be
especially higher in the younger age group (<60 years).5,28–30,56
Accordingly, we studied sex differences in post-PCI TIMI flow
sorted by younger versus older age. Women had higher rates of
post-PCI TIMI flow grade 0 to 2 than men only in patients aged
≥60 years. This is consistent with the hypothesis that the
association between female sex and excessmortality in STEMI is
not attributable to only 1 factor (namely, post-PCI TIMI flow). An
important reason for the relatively higher mortality rates in
younger women may be the occurrence of coronary spasm or
dysfunction a few days after PCI.57 Diagnosis can be difficult,
given the transience of coronary spasm, and might require more
sophisticated diagnostic approaches than those used in current
practice, as reflected by our registry study.
Limitations
We cannot rule out that more men and women died before
presentation to the hospitals; therefore, the mortality rates of
the current study only reflect those of patients who reach the
hospital. As an observational study, we cannot completely
exclude residual confounding, even using IPTW analyses. On
the other hands, one cannot randomize patients to sex.
Because catheterization data were mandated as part of the
registry protocol only in centers with PCI facilities, patient
selection may have introduced potential referral bias. How-
ever, the external validity of this study is confirmed by the
proportion of patients with post-PCI TIMI flow grade 0 to 2
in the overall population, which is similar to previous
estimates.58 Furthermore, the demographics, characteristics,
and 30-day mortality rates of patients in this study were
similar to those reported by recent research.59 Finally, results
may not be definitive without replication.
Conclusions
To date, most studies focused only on female sex, whereas
little or no specific data on comparison between sexes are
available.6,60,61 The current study is the first investigation that
estimated and reported heterogeneity of treatment effects
after primary PCI among women and men. We provided data
disaggregated by sex and gave insights into how sex may be
relevant as a biological variable. Female sex has a distinct
cardiovascular blood flow reactivity after primary PCI, regard-
less of time to hospital presentation. Furthermore, women are
more vulnerable to prolonged untreated ischemia. For late
STEMI presentations, women have a 2-fold likelihood of
mortality compared with men. These results provide motiva-
tion for adequate consideration of both sexes in experiments
and disaggregation of data by sex, which may allow for sex-
based comparisons and may inform clinical interventions.
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